Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubha Bhat

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Crohn'S & Colitis 360|February 13, 2023
Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease: A Review of Existing Literature and Best PracticesShubha Bhat, Taha Qazi
Journal of Crohn'S & Colitis|July 1, 2022
Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy?Shubha Bhat, Florian Rieder
Current Gastroenterology Reports|January 19, 2024
Biosimilars in IBD: What Every Clinician Needs to KnowAnthony Angyal, Shubha Bhat
The Annals of Pharmacotherapy|January 13, 2025
Guselkumab: A New Therapeutic Option for the Treatment of Moderately to Severely Active Ulcerative ColitisShubha Bhat, David Choi
The Annals of Pharmacotherapy|May 29, 2021
Pharmacist-Managed <i>Helicobacter pylori</i> Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World ExperiencesShubha Bhat, David Nunes
The Annals of Pharmacotherapy|July 1, 2021
Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel DiseaseJi Yoon Kim, Shubha Bhat
Gastroenterology & Hepatology|August 29, 2024
Clinical Guide to Navigating the Landscape of Biosimilars for Inflammatory Bowel DiseaseShubha Bhat, Sunanda V Kane
Inflammatory Bowel Diseases|July 14, 2023
Safety and Monitoring of Inflammatory Bowel Disease Advanced TherapiesShubha Bhat, Benjamin Click, Miguel Regueiro
The Annals of Pharmacotherapy|October 10, 2022
Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's DiseaseDavid Choi, Hilary Sheridan, Shubha Bhat
Indian Journal of Surgical Oncology|October 22, 2020
Correction to: Metachronous Sarcomas-a Case ReportAshwathy Pradeep, K Sajitha, Shubha Bhat
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Crohn'S & Colitis 360|February 13, 2023
Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease: A Review of Existing Literature and Best PracticesShubha Bhat, Taha Qazi
Journal of Crohn'S & Colitis|July 1, 2022
Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy?Shubha Bhat, Florian Rieder
Current Gastroenterology Reports|January 19, 2024
Biosimilars in IBD: What Every Clinician Needs to KnowAnthony Angyal, Shubha Bhat
The Annals of Pharmacotherapy|January 13, 2025
Guselkumab: A New Therapeutic Option for the Treatment of Moderately to Severely Active Ulcerative ColitisShubha Bhat, David Choi
The Annals of Pharmacotherapy|May 29, 2021
Pharmacist-Managed <i>Helicobacter pylori</i> Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World ExperiencesShubha Bhat, David Nunes
The Annals of Pharmacotherapy|July 1, 2021
Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel DiseaseJi Yoon Kim, Shubha Bhat
Gastroenterology & Hepatology|August 29, 2024
Clinical Guide to Navigating the Landscape of Biosimilars for Inflammatory Bowel DiseaseShubha Bhat, Sunanda V Kane
Inflammatory Bowel Diseases|July 14, 2023
Safety and Monitoring of Inflammatory Bowel Disease Advanced TherapiesShubha Bhat, Benjamin Click, Miguel Regueiro
The Annals of Pharmacotherapy|October 10, 2022
Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's DiseaseDavid Choi, Hilary Sheridan, Shubha Bhat
Indian Journal of Surgical Oncology|October 22, 2020
Correction to: Metachronous Sarcomas-a Case ReportAshwathy Pradeep, K Sajitha, Shubha Bhat
Pageof 6